WFPF_support_groupslogo2

FDA approval of Esbriet (pirfenidone) [InterMune] and Ofev (nintedanib) [Boehringer Ingelheim] for treatment of IPF

Wescoe Foundation for Pulmonary Fibrosis is proudly recognized by the Pennsylvania Association of Nonprofit Organizations as having met all the requirements of the Standards Basics program.

229 N. Main St. Coopersburg, PA 18036
jennifer@wescoe.org | 484-553-6340
PRIVACY POLICY